Current Fellows

Each year, 10 to 11 new fellows join the NIH Hematology Oncology Fellowship on July 1. After a week-long orientation to our large campus and learning the ins and outs of the iconic Building 10, they begin their rotations both on and off campus. By the end of their first year, single-boarding fellows are ready to begin their research time.

Fellows who are double-boarding in hematology and oncology spend the first six months of their second year completing their rotations. Then they join their singe-boarding colleagues in focusing on their research. (See Pathway to Research Independence on the Fellowship Experience page for more information.) At the end of their second year, single-boarding fellows are ready to graduate (but they often stay to continue their research during their guaranteed third year). 

Whether they are single- or double-boarding, all NIH hematology oncology fellows are guaranteed three years of fellowship. Double-boarding fellows graduate at the end of their third year.  

A small percentage of our fellows stay for four years if they are on the ABIM Research Pathway or also doing pediatric hematology and/or oncology.  After our fellows graduate, the majority stay in academia, many by staying on at NIH. A percentage of our fellows also go on to work in community and/or hybrid practices, others go to industry, and some move to the U.S. Food and Drug Administration to serve as regulators. See our Alumni page to learn more.

Matriculating Class of 2024

Image
Matriculating Class of 2024
Matriculating Class of 2024: Biplov Adhikari, M.B.B.S.; Yoonhee Choi, M.D.; Brooke Kania, D.O.; Sabin Kshattry, M.D., Ph.D.; Bari Rosenberg, M.D.; Miles Hsu, M.D., M.S.; Amanda Walker, M.D.; Aanika Warner, M.D., M.P.H.; Chantal Saberian, M.D.; Farzeen Syed, D.O.; and Fieke Hoff, M.D., Ph.D.

Matriculating Class of 2023

Image
2023 Heme Onc Fellowship Matriculating Class
Matriculating Class of 2023: Catarina Martins Maia, M.D.; Chirayu Mohindroo, MBBS; Anna Meinhardt, M.D.; Peter Egwom, M.D.; Marni McClure, M.D., Ph.D. (on the ABIM Research Pathway); Jose Mercado-Matos, M.D., Ph.D.; Catherine Ostos Perez, M.D.; Maggie Pruitt, M.D., Ph.D.; Elizabeth Francis, M.D., MPH (in our joint Cancer Prevention program); Nicholas Lee, M.D. (who is also studying pediatric hematology and oncology); and Gonca Ozcan, M.D. 

Matriculating Class of 2022

Image
Heme Onc Fellowship Matriculating Class of 2022
Matriculating Class of 2022: Laercio DaSilva, M.D.; Raissa Kentsa, M.D.; Tatyana Gavrilova, M.D.; Ira Lignugaris Kraft, M.D. (in combined program with pediatric hematology oncology); Roshani Patel, M.D.; Saad Atiq, M.D.; Disha Dalela, M.D.; Norihiro Yamaguchi, M.D., MPH, M.Sc.; Maria Farooq, M.D.; Andre Kydd, M.D., Ph.D.; Joy Awosika, M.D.; and Christine Gruessner, M.D.

Matriculating Class of 2021

Image
Heme Onc Fellowship Matriculating Class of 2021
Matriculating Class of 2021: Harold Elias, M.D.; Melissa Abel, M.D.; Jamie Hur, D.O.; Kelley Coffman, M.D.; Brett Schroeder, M.D.; Nirmal Choradia, M.D. (in combined Cancer Prevention program); Elias Chandran, MBBS (advanced genitourinary fellow); Princess Mark-Adjeli, M.D., MPH; Etan Aber, M.D., Ph.D. (on ABIM Research Pathway); Rebecca Bystrom, M.D.; Nick Tschernia, M.D. (immunotherapy fellow); Stacey Doran, M.D.; Ian Allen, M.D.; and Ian Goldlust, M.D., Ph.D. (on ABIM Research Pathway).